comparemela.com

Latest Breaking News On - Tony kingsley - Page 1 : comparemela.com

Stablix, Vertex partner to develop targeted protein stabilisation therapies

Stablix and Vertex Pharmaceuticals have joined forces to discover and develop targeted protein stabilisation (TPS) therapies.

Q&A: Summit Health CEO on its growth projections and the future of urgent care

Plus: Englewood Health opens urgent care site in Jersey City Nursing homes should boost education to ease patient transitions, report says Stony Brook diagnostics manufacturer's revenue more than doubles in fiscal Q1

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation

Share this article Share this article NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Scholar Rock Holding Corporation ( Scholar Rock or the Company ) (NASDAQ: SRRK).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Scholar Rock and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  On August 3, 2021, Scholar Rock issued a press release announcing the abrupt departure of Company President and Chief Executive Officer Tony Kingsley, who had served in both roles since August 2020, without providing any explanation. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.